ArticleThe Prostate2006

Antitumor activity and downregulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compound.

Fuminori Teraishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.